The Microvascular Response to Transdermal Iontophoresis of Insulin is Mediated by Nitric Oxide

Microcirculation

Volumn 20, Issue 8, 2013, Pages 717-723

  Iredahl, Fredrik ^a   Tesselaar, Erik ^a   Sarker, Saikat ^a   Farnebo, Simon ^b   Sjöberg, Folke ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Operations and Specialty Surgery Center   (Sweden)

Author keywords

Endothelial function; Insulin; Transdermal iontophoresis; Vasodilation

Indexed keywords

EMLA; HUMAN INSULIN; INSULIN ASPART; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DELIVERY DEVICE; FEMALE; HUMAN; HUMAN EXPERIMENT; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; LASER FLOWMETER; MALE; MECHANICAL PROBE; MONITOR; NORMAL HUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN ELECTRODE; SKIN PENETRATION; SKIN TEMPERATURE; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ENDOTHELIAL FUNCTION; INSULIN; TRANSDERMAL IONTOPHORESIS; VASODILATION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; IONTOPHORESIS; MALE; MICROCIRCULATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SKIN; VASODILATION;

EID: 84887203547     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12071     Document Type: Article

References (31)

1. Avontuur JA, Buijk SL, Bruining HA. Distribution and metabolism of N(G)-nitro-l-arginine methyl ester in patients with septic shock. Eur J Clin Pharmacol 54: 627-631, 1998.
2. Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, Liu Z. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 52: 752-764, 2009.
3. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 100: 820-825, 1999.
4. Clark MG. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab 295: E732-E750, 2008.
5. Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S, Barrett E. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 50: 2682-2690, 2001.
6. de Jongh RT, Serne EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109: 2529-2535, 2004.
7. de Jongh RT, Serne EH, IJzerman RG, Jorstad HT, Stehouwer CD. Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women. Microvasc Res 75: 256-262, 2008.
8. Delaney C, Shaw J, Day T. Acute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in Type 1 diabetes mellitus. Diabet Med 21: 428-433, 2004.
9. Droog EJ, Henricson J, Nilsson GE, Sjoberg F. A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects. Microvasc Res 67: 197-202, 2004.
10. Droog EJ, Sjoberg F. Nonspecific vasodilatation during transdermal iontophoresis-the effect of voltage over the skin. Microvasc Res 65: 172-178, 2003.
11. Eggleston EM, Jahn LA, Barrett EJ. Hyperinsulinemia rapidly increases human muscle microvascular perfusion but fails to increase muscle insulin clearance: evidence that a saturable process mediates muscle insulin uptake. Diabetes 56: 2958-2963, 2007.
12. Henricson J, Tesselaar E, Persson K, Nilsson G, Sjoberg F. Assessment of microvascular function by study of the dose-response effects of iontophoretically applied drugs (acetylcholine and sodium nitroprusside) - methods and comparison with in vitro studies. Microvasc Res 73: 143-149, 2007.
13. Horiuchi Y, Droog EJ, Henricson J, Wikström T, Lennquist S, Sjöberg F. Role of histamine release in nonspecific vasodilatation during anodal and cathodal iontophoresis. Microvasc Res 67: 192-196, 2004.
14. Kanikkannan N, Singh J, Ramarao P. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. J Control Release 59: 99-105, 1999.
15. Langkjaer L, Brange J, Grodsky GM, Guy RH. Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment. J Control Release 51: 47-56, 1998.
16. Medow MS, Minson CT, Stewart JM. Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome. Circulation 112: 2611-2618, 2005.
17. Meneilly GS, Elliott T, Battistini B, Floras JS. N(G)-monomethyl-l-arginine alters insulin-mediated calf blood flow but not glucose disposal in the elderly. Metabolism 50: 306-310, 2001.
18. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, Isner JM. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 19: 1156-1161, 1999.
19. O'Doherty J, Henricson J, Anderson C, Leahy MJ, Nilsson GE, Sjoberg F. Sub-epidermal imaging using polarized light spectroscopy for assessment of skin microcirculation. Skin Res Technol 13: 472-484, 2007.
20. Pillai O, Nair V, Panchagnula R. Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers. Int J Pharm 269: 109-120, 2004.
21. Richards OC, Raines SM, Attie AD. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev 31: 343-363, 2010.
22. Rossi M, Maurizio S, Carpi A. Skin blood flowmotion response to insulin iontophoresis in normal subjects. Microvasc Res 70: 17-22, 2005.
23. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94: 2511-2515, 1994.
24. Serne EH, IJzerman RG, Gans RO, Nijveldt R, De VG, Evertz R, Donker AJ, Stehouwer CD. Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia. Diabetes 51: 1515-1522, 2002.
25. Serne EH, Stehouwer CD, ter Maaten J, ter Wee P, Rauwerda JA, Donker AJ, Gans RO. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 99: 896-902, 1999.
26. Steinberg HO, Baron AD. Insulin-dependent diabetes mellitus and nitrovasodilation. Important and complex interactions. Circulation 95: 560-561, 1997.
27. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179, 1994.
28. Tesselaar E, Sjoberg F. Transdermal iontophoresis as an in-vivo technique for studying microvascular physiology. Microvasc Res 81: 88-96, 2011.
29. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285: E123-E129, 2003.
30. Vincent MA, Clerk LH, Lindner JR, Klibanov AL, Clark MG, Rattigan S, Barrett EJ. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53: 1418-1423, 2004.
31. Wiernsperger N. Is defective microcirculation responsible for insulin resistance? In: Microcirculation and Insulin Resistance, edited by Wiernsperger N. Sharjah, UAE: Bentham Science Publishers, 2009, pp. 119-167.